stents. Single and OL SES eluted > 90% of sirolimus loaded by Day 60. Sirolimus elution rate and arterial content in all 3 cohorts declined quickly to similar levels by Day 3. Though OL NEVO™ stents eluted 3.7-fold more sirolimus than single NEVO™ stents by Day 1 (28.8±7.4 vs 7.7±3.1 μg), arterial content was not statistically different, indicating that local drug delivery to the artery wall from OL SES is dominated by the wall-apposed stent. This inference is supported by the fact that peak sirolimus blood level in OL NEVO™ and OL 2x-NEVO™ stents was 5.5-to 9.8-fold higher than single NEVO™ stents (3.31±1.13 and 5.89±1.75 vs 0.60±0.27 ng/ml). Sirolimus levels in blood, myocardium, and peripheral organs declined below the limit of quantification by Day 60. Conclusion: Our data show that overlapping NEVO™ stents do not influence sirolimus elution rate and that wall apposition dominates local arterial delivery. Systemic sirolimus exposure remains below toxic levels at all times even for OL 2x-NEVO™ stents, presumably due to fast hydrolytic degradation of free sirolimus in blood and hepatic metabolism.
Background: Previous research from our group has demonstrated trioxide (As2O3) eluting stents (AESs) significantly reduced neointimal area and thickness compared with bare metal stents . In the present study, we explored the anti-inflammatory effect of As2O3 in vitro and in vivo for understanding the mechanism of AESs in reducing in-stent restenosis. Methods: Human dendritic cells and T lymphocytes were co-cultured with different concentrations of As2O3. Effect of As2O3 on apoptosis, phenotypic characterization, and cytokines production of these two kinds of inflammatory cells were evaluated by flow cytometry and enzyme-linked immunosorbent assays. Sixty-five pigs underwent placement of 139 oversized stents in the coronary arteries with histologic analysis, As2O3 levels evaluation, endothelial function analysis, immunohistochemical and western blot analysis. Results: As2O3 induced apoptosis of human T lymphocytes and dendritic cells in a dose-dependent manner. AESs induced less foreign body reactions of fibrin-platelet deposition and acute inflammatory cells infiltration than BMSs and polymer-coated stents (PCSs). There was no significant difference in extensive endothelialization and endothelial function between AESs and BMSs after 4 weeks post stent implantation. Stent-based As2O3 delivery effectively inhibited expression of inflammationassociated proteins such as monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6), in agreement with the western blotting results. Conclusion: As2O3 eluting stents favorably modulate neointimal formation 4 weeks after stent implantation. The quick elution of the drug from the biodegradable coating material, less augmentation of early inflammatory reactions, and quick endothelialization of the stent surface might contribute to the long-term safety and efficacy. Background: Optical coherence tomography (OCT) has the ability to detect small changes in peri-strut neointimal formation, however, its ability to characterize tissue types is still limited. In this study, we aimed to compare different characteristics of instent neointimal tissue in OCT with types analyzed by histology. Methods: A total of 69 stents [39 DES and 30 BMS] were implanted in coronary arteries of 27 swine. By OCT, neointimal type was classified as homogeneous, heterogeneous or layered pattern according to its pattern of backscatter and optical density. These resulting optical patterns were correlated with histological findings (external elastic lamina (EEL) disruption, significant fibrin deposition, circumferential rim of peri-strut inflammatory cell infiltration and collagen deposition) in every crosssection (CS). Results: A total of 197 OCT and histological CS were well matched. The heterogeneous (0.44±0.21mm) and layered (0.65±0.16mm) patterns had a significantly higher degree of neointimal thickness compared to the homogeneous pattern (0.25±0.16 mm, p<0.001). Collagen deposition was more frequently present in the homogeneous pattern (72%), whereas significant fibrin deposits were more commonly seen in the heterogeneous pattern (57%). Peri-strut inflammation was less frequently found in the homogeneous pattern (19.8%) in comparison to the layered (73.9%) or heterogeneous patterns (43.1%). Presence of EEL rupture behaved similarly (73.9% in layered, 46.6% in heterogeneous, 22.4% in homogeneous pattern). Optical density analyses showed that the homogeneous pattern had the narrowest standard deviation (0.09±0.10 vs. 0.26±0.22 in heterogeneous and 0.42±0.24 in layered pattern) and the highest mean value (105.9±17.6 vs. 83.0±17.1 in heterogeneous and 84.0±12.9 in layered pattern). Conclusion: The optical characteristics of neointimal formation seen in OCT properly correlated with the presence of several histological findings involved in stent healing. The biological implications of these findings in clinical outcomes require further investigation.
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Optical Characteristics of Neointimal Formation Correlate with Histological Markers of Stent Healing in a Porcine Model of Restenosis
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Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model Li Shen 1 , Qibing Wang 1 , Yizhe Wu 1 , Jian Xie 2 , Junbo Ge 1 1 Shanghai Institute of Cardiovascular Diseases and Cardiology Department, Zhongshan Hospital, Shanghai, China, Shanghai, China; 2 Shandong Huaan Biotechnology Co., Ltd, , Laiwu, China Background: Conventional metallic, drug-eluting stents (DES) restrict restenosis after percutaneous coronary intervention (PCI). However, stents can generate additional foreign body reactions and consequently increase the possibility of adverse events.Bioresorbable polymeric scaffolds have been suggested as a possible solution. In this study, short-term effects of fully bioabsorbable sirolimus-loaded poly-l-lactic acid (PLLA) stents (Xinsorb) were evaluated in a porcine coronary model to assess the technical feasibility, biocompatibility, and effects on coronary stenosis. Methods: PLLA stents (Xinsorb, Huaan Biotechnology Co., Ltd, China) were coated with 140 μg/cm2 of sirolimus. Commercially available sirolimus-eluting stents (Excel, JW Medical System, China) were used as controls. Xinsorb stents (n=16) and Excel stents( n=16) were randomly implanted in porcine coronary arteries. Neointima formation was measured by angiography and histomorphometry at 30 and 90 days. Additionally,inflammation score and endothelial cell recovery were measured. Results: The Xinsorb stents can be delivered and expanded at high pressure compared with Excel stents, without any fracture and acute recoil. Both had a remarkable effect on reducing neointimal hyperplasia,since no distinctive vessel narrowing greater than 50% were observed by angiography.By histomorphometry,at 30 and 90 days, coronary stenosis was 18.6 ± 5.2 vs. 21.4 ± 7.2% and 24.5 ± 4.7 vs. 27.7 ± 5.6% respectively (p > 0.05), after Xinsorb and Excel stent implantations. The inflammation scores were 0.84 ± 0.15 vs. 0.74 ± 0.10 and 0.93 ± 0.26 vs. 0.88 ± 0.10, respectively (p > 0.05). At 90 days, through scanning electron microscopy, Xinsorb and Excel stents were all completely endothelialized, though they mildly delayed reendothlialization at 30 days. Conclusion: Xinsorb stents reliably supported blood vessels and favourably modulated neointimal formation at least at 90 days in a porcine coronary model. No safety concerns regarding inflammatory reactions and in-stent thrombosis were observed.The long-term safty and efficacy of the stents will be validated.
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Angiographic and Histological Response Following Implantation of a Novel Stent-On-A-Wire in the Animal Model
Roberto Diletti 1 , Hector M Garcia-Garcia 1 , Lynn Bailey 2 , Serge Rousselle 3 , Gregory Kopia 4 , William Easterbrook 5 , Mark Pomeranz 5 , Patrick Serruys 1 1 Interventional Cardiology, Erasmus MC, Rotterdam, Netherlands; 2 CBSET Inc. USA, Lexington, MA; 3 Alizee Pathology, Thurmont, MD; 4 Kopia Consulting, Hillsborough, NJ; 5 Svelte Medical Systems, , New Providence, NJ Background: The Svelte Stent-on-a-Wire (SOAW) is a thin strut novel device consisting of a balloon expandable cobalt chromium stent premounted onto a single lumen fixed-wire delivery catheter platform. We evaluated the performance of the novel Svelte Stent-on-a Wire, in comparison with the MultiLink Vision (ML Vision) balloon expandable stent, in porcine coronary arteries. Methods: Eight Yorkshire swine (30-day follow-up cohort) and 7 Yucatan mini-swine (90-day follow-up cohort) were implanted with either Svelte SOAW or control ML Vision. Acute performance characteristics were graded by interventionalists during implantation. Angiographic assessments were performed at the index procedure and at 30 or at 90 days post-implantation. Scanning electron microscopy (SEM) histological and histomorphometric analysis of stented segments were performed after angiographic follow-up. Results: Acute implantation performance was similar between the 2 stents however deflation time was significantly lower in the Svelte SOAW group (9.56±0.96 s vs 4.70±0.93 s, p < 0.05). Angiographic late loss was similar for both stents at 30 (0.83±0.59 mm vs 0.88±0.71mm, p=0.969) and at 90 days (0.76±0.35 mm vs 0.83±0.35 mm, p=0.679). SEM analysis showed complete endothelialization at 30 days in both stent types. The presence of inflammatory cells was minimal and equivalent for both stent treatments at both time points. There was no in-stent thrombus in either stent group. Histopathological assessment demonstrated minimal injury and equivalent inflammation at 30 and 90 days with Svelte SOAW and ML Vision stents as well as endothelialization, neointimal maturation, adventitial fibrosis and neointimal fibrin. Histomorphometric analysis showed no differences between the 2 groups in stent, lumen, media or neointimal areas at either 30 or 90 days post-implantation. 
Conclusion
